3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
2
Status
Unknown
2
Recruiting
2
Not yet recruiting
1
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Cancer Type
Gastrointestinal
2
Conditions
Pancreatic Neoplasms
6
Neoplasm Metastasis
2
Colorectal Neoplasms
2
Solid Tumor
1
Sarcoma, Ewing
1
Rhabdomyosarcoma
1
Recurrence
1
Pancreatic Cancer Non-resectable
1
Pancreatic Adenocarcinoma
1
Osteosarcoma
1
Neuroblastoma
1
Gastrointestinal Neoplasms
1
Borderline Resectable Pancreatic Cancer
1
Biliary Tract Neoplasms
1
Advanced Esophageal Squamous Cell Cancer
1
Interventions
Fluorouracil
18
Oxaliplatin
17
Capecitabine
16
Leucovorin
13
Cisplatin
12
Gemcitabine
11
Drug Therapy
11
Irinotecan
10
Radiosurgery
9
Cetuximab
9
Bevacizumab
9
pembrolizumab
8
Docetaxel
8
Everolimus
7
spartalizumab
6
Sunitinib
6
Radiotherapy
6
Paclitaxel
6
Neoadjuvant Therapy
6
Cyclophosphamide
6
Trastuzumab
5
S 1 (combination)
5
Nivolumab
5
Immunotherapy
5
Immune Checkpoint Inhibitors
5
Chemotherapy, Adjuvant
5
Carboplatin
5
palbociclib
4
manganese chloride
4
Surgical Procedures, Operative
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Unknown
×
Neoplasm Metastasis
×
irinotecan sucrosofate
×
Clear all
NCT04617457
2024-01-12
HOLIPANC
University of Cologne
Phase 2
Unknown
150 enrolled
NCT03487016
2022-09-08
FOOTPATH
Ludwig-Maximilians - University of Munich
Phase 2
Unknown
270 enrolled